Samsung Biologics inks biosimilar manufacturing deal with Pfizer
Medicamente biosimilare, de ce are nevoie România să le adopte la scară largă | DCMedical.ro
Biosimilars in oncology: challenges and opportunities | Cancer World Archive
Zilele Spitalului Universitar de Urgenta Militar Central Dr. Carol Davila – Galerie multimedia
Biosim - recenzii, fotografii, număr de telefon și adresă - Centre medicale din Târgu Mureș - Nicelocal.ro
Switchback BioSim Innovations is excited to transition into our new space with expanded lab space, new project development labs, and a larger team! We... | By Switchback Medical | Facebook
dr reddy: Dr Reddy's completes clinical studies of its proposed rituximab biosimilar candidate - The Economic Times
Foundation hosts event to launch report on generic & biosimilar medicine manufacturers | Access to Medicine Foundation
Biosimilar uptake will take more than competitive pricing
Biosimilar Drug Master Class | McKesson
MSD launches first Herceptin biosimilar in UK
Integrated Biopharma AND Pharma Solution on LinkedIn: Eculizumab biosimilar gets positive CHMP opinion
Multiple infliximab biosimilar switches appear to be safe and effective in a real‐world inflammatory bowel disease cohort - Gros - 2023 - United European Gastroenterology Journal - Wiley Online Library
Biocon, Mylan Launch Fulphila, Biosimilar Pegfilgrastim in Australia
Sandoz Biosimilar Technical Development Centre, Slovenia
Seminarul științific BIOSIM – DDS Diagnostic
Seminarul științific BIOSIM – DDS Diagnostic
Polaris Medical - cel mai mare spital privat de recuperare medicala din Romania - YouTube
Expert: generation of biobetters could push out biosimilar development
Guide on Biosimilar Medicines – uemo
ADVANZ PHARMA enters into an exclusive agreement with Alvotech to commercialise a proposed biosimilar to Xolair® (omalizumab) | ADVANZ PHARMA
Ogivri, trastuzumab biosimilar, eficient și sigur pentru tratamentul cancerului mamar și cancerului gastric HER2-pozitive
Literature review of international biosimilar medicines update – December 2016 to March 2017 | Australian Government Department of Health and Aged Care
BioSim Research Group | Porto
